PL375113A1 - Casein derived peptides and uses thereof in therapy - Google Patents

Casein derived peptides and uses thereof in therapy

Info

Publication number: PL375113A1
Authority: PL; Poland
Prior art keywords: peptides; therapy; casein; derived peptides; derived
Prior art date: 2001-08-30

Application number

PL02375113A

Other languages

English (en)

Polish (pl)

Inventor

Zvi Sidelman

Original Assignee

Chay 13 Medical Research Group N.V.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-08-30

Filing date

2002-08-29

Publication date

2005-11-28

2001-08-30 Priority claimed from US09/942,121 external-priority patent/US20020147144A1/en

2002-08-29 Application filed by Chay 13 Medical Research Group N.V. filed Critical Chay 13 Medical Research Group N.V.

2005-11-28 Publication of PL375113A1 publication Critical patent/PL375113A1/xx

Links

102000004196 processed proteins & peptides Human genes 0.000 title abstract 4
108090000765 processed proteins & peptides Proteins 0.000 title abstract 4
239000005018 casein Substances 0.000 title abstract 3
BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 title abstract 3
235000021240 caseins Nutrition 0.000 title abstract 3
238000002560 therapeutic procedure Methods 0.000 title 1
230000004936 stimulating effect Effects 0.000 abstract 2
208000035150 Hypercholesterolemia Diseases 0.000 abstract 1
208000036142 Viral infection Diseases 0.000 abstract 1
HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 abstract 1
201000010099 disease Diseases 0.000 abstract 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
230000002708 enhancing effect Effects 0.000 abstract 1
208000014951 hematologic disease Diseases 0.000 abstract 1
230000011132 hemopoiesis Effects 0.000 abstract 1
230000028993 immune response Effects 0.000 abstract 1
235000013336 milk Nutrition 0.000 abstract 1
239000008267 milk Substances 0.000 abstract 1
210000004080 milk Anatomy 0.000 abstract 1
231100000252 nontoxic Toxicity 0.000 abstract 1
230000003000 nontoxic effect Effects 0.000 abstract 1
230000007170 pathology Effects 0.000 abstract 1
230000009385 viral infection Effects 0.000 abstract 1
230000003612 virological effect Effects 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4732—Casein
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Organic Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Immunology (AREA)
Diabetes (AREA)
Hematology (AREA)
Oncology (AREA)
Virology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
Zoology (AREA)
Toxicology (AREA)
Communicable Diseases (AREA)
Epidemiology (AREA)
Obesity (AREA)
Molecular Biology (AREA)
Emergency Medicine (AREA)
Marine Sciences & Fisheries (AREA)
Endocrinology (AREA)
Tropical Medicine & Parasitology (AREA)
AIDS & HIV (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

PL02375113A 2001-08-30 2002-08-29 Casein derived peptides and uses thereof in therapy PL375113A1 (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US09/942,121 US20020147144A1 (en)	2000-03-01	2001-08-30	Casein derived peptides and uses thereof in therapy

Publications (1)

Publication Number	Publication Date
PL375113A1 true PL375113A1 (en)	2005-11-28

Family

ID=25477603

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL02375113A PL375113A1 (en)	2001-08-30	2002-08-29	Casein derived peptides and uses thereof in therapy

Country Status (15)

Country	Link
EP (1)	EP1556074A4 (fr)
JP (1)	JP2005511499A (fr)
KR (1)	KR20040078639A (fr)
CN (1)	CN1694719A (fr)
AU (1)	AU2002324323A2 (fr)
BR (1)	BR0212625A (fr)
CA (1)	CA2458924A1 (fr)
CZ (1)	CZ2004335A3 (fr)
HU (1)	HUP0500995A3 (fr)
IL (1)	IL160548A0 (fr)
MX (1)	MXPA04001890A (fr)
NO (1)	NO20040880L (fr)
PL (1)	PL375113A1 (fr)
WO (1)	WO2003018606A2 (fr)
ZA (1)	ZA200401574B (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0313892D0 (en) *	2003-06-16	2003-07-23	Hannah Res Inst	Control of lactation
WO2005074599A2 (fr) *	2004-01-30	2005-08-18	Chemgenex Pharmaceuticals, Inc.	Dosage de naphthalimide par genotypage de n-acetyle transferase
EA200601575A1 (ru) *	2004-03-01	2007-06-29	Пептера Фармасьютикалс Лтд.	Казеиновые пептиды и их терапевтическое применение
GB0423352D0 (en) *	2004-10-21	2004-11-24	Hannah Res Inst	"Control of mammary cell number"
ES2319475B1 (es) *	2005-06-08	2010-02-16	Consejo Superior Investig. Cientificas	Peptidos bioactivos identificados en hidrolizados enzimaticos de caseinas lacteas y procedimiento de obtencion.
JP4394155B2 (ja) *	2006-06-09	2010-01-06	森永乳業株式会社	脂質代謝改善剤
JP2011026213A (ja) *	2009-07-22	2011-02-10	Snow Brand Milk Prod Co Ltd	１型糖尿病抑制ペプチド
CA2870537A1 (fr) *	2012-04-16	2013-10-24	The Cleveland Clinic Foundation	Vaccin multivalent contre le cancer du sein
AU2018227125A1 (en) *	2017-03-03	2019-10-24	Morinaga Milk Industry Co., Ltd.	GLP-1 secretagogue and composition
CN107814835B (zh) *	2017-12-01	2020-04-28	熊猫乳品集团股份有限公司	一种生物活性多肽avpitptlnreq及其制备方法和应用
CN108017709B (zh) *	2017-12-12	2020-04-10	浙江辉肽生命健康科技有限公司	一种生物活性多肽kepmigvnqela及其制备方法和应用
CN113952446B (zh) *	2021-09-03	2023-12-05	河南省医药科学研究院	生物活性肽在抑制骨髓毒性中的应用
CN120815163B (zh) *	2025-09-16	2025-12-12	华中科技大学同济医学院附属同济医院	能抑制ccnb2表达的抗肿瘤药物和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3778426A (en) *	1970-12-16	1973-12-11	Research Corp	Therapeutically useful polypeptides
AU729978B2 (en) *	1997-03-21	2001-02-22	Snow Brand Milk Products Co., Ltd.	Iron-partial hydrolyzates of casein complexes and processes for preparation thereof
IL134830A0 (en) *	2000-03-01	2001-05-20	Chay 13 Medical Res Group N V	Peptides and immunostimulatory and anti-bacterial pharmaceutical compositions containing them

2002
- 2002-08-29 JP JP2003523265A patent/JP2005511499A/ja active Pending
- 2002-08-29 IL IL16054802A patent/IL160548A0/xx unknown
- 2002-08-29 KR KR10-2004-7002884A patent/KR20040078639A/ko not_active Withdrawn
- 2002-08-29 HU HU0500995A patent/HUP0500995A3/hu unknown
- 2002-08-29 BR BRPI0212625-7A patent/BR0212625A/pt not_active IP Right Cessation
- 2002-08-29 CZ CZ2004335A patent/CZ2004335A3/cs unknown
- 2002-08-29 CA CA002458924A patent/CA2458924A1/fr not_active Abandoned
- 2002-08-29 CN CNA028216741A patent/CN1694719A/zh active Pending
- 2002-08-29 MX MXPA04001890A patent/MXPA04001890A/es not_active Application Discontinuation
- 2002-08-29 EP EP02758768A patent/EP1556074A4/fr not_active Withdrawn
- 2002-08-29 PL PL02375113A patent/PL375113A1/xx not_active Application Discontinuation
- 2002-08-29 WO PCT/IL2002/000720 patent/WO2003018606A2/fr not_active Ceased
- 2002-08-29 AU AU2002324323A patent/AU2002324323A2/en not_active Abandoned
2004
- 2004-02-26 ZA ZA200401574A patent/ZA200401574B/en unknown
- 2004-02-27 NO NO20040880A patent/NO20040880L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
WO2003018606A9 (fr)	2004-04-08
WO2003018606A2 (fr)	2003-03-06
EP1556074A2 (fr)	2005-07-27
KR20040078639A (ko)	2004-09-10
ZA200401574B (en)	2007-02-28
AU2002324323A2 (en)	2003-03-10
WO2003018606A3 (fr)	2005-05-06
JP2005511499A (ja)	2005-04-28
HUP0500995A2 (en)	2007-05-02
BR0212625A (pt)	2007-06-19
MXPA04001890A (es)	2004-06-18
CA2458924A1 (fr)	2003-03-06
HUP0500995A3 (en)	2008-09-29
CZ2004335A3 (cs)	2004-07-14
IL160548A0 (en)	2004-07-25
NO20040880L (no)	2004-04-20
CN1694719A (zh)	2005-11-09
EP1556074A4 (fr)	2008-05-07

Publication	Publication Date	Title
EP1261360A4 (fr)	2004-03-10	Peptides derivant de la caseine et leurs emplois therapeutiques
WO2005081628A3 (fr)	2007-10-18	Peptides derives de la caseine et leurs utilisations therapeutiques
ATE314095T1 (de)	2006-01-15	Virusähnliche partikel zur induktion von autoantikörpern
PL375113A1 (en)	2005-11-28	Casein derived peptides and uses thereof in therapy
AU1685499A (en)	1999-07-19	Polypeptide, their production and use
WO2003047524A3 (fr)	2003-09-12	Methodes et compositions permettant la modulation du systeme immunitaire et utilisations de celles-ci
DE69841982D1 (de)	2010-12-16	Zusammensetzungen zum einsatz in einer gentherapie zur behandlung von hämophilie
WO2000075173A3 (fr)	2002-07-11	Peptides
WO2003048205A3 (fr)	2004-01-22	Proteines a activite inhibitrice de l'il-6
FR2870126A1 (fr)	2005-11-18	Vecteur lentiviral recombinant d'expression d'une proteine de flaviviridae et ses applications comme vaccin
WO2001045738A3 (fr)	2001-12-27	Utilisation de proteines de choc thermique
WO2001004318A3 (fr)	2001-08-09	Nouveaux genes de virus de la myxomatose pour immunomodulation
GB2374871A (en)	2002-10-30	Peptide fragments of colostrinin and their use
WO2004006843A3 (fr)	2004-07-22	Polytherapies a base de l-fmau pour le traitement de l'infection par le virus de l'hepatite b
MD2053B1 (en)	2002-12-31	Remedy with interferon inducing action
WO2000077177A3 (fr)	2001-08-23	Isolation d'un retrovirus humain
GB0415437D0 (en)	2004-08-11	Recombinant virus
MXPA05007901A (es)	2005-09-21	Terapia de combinacion para hcv.
WO2001087333A3 (fr)	2002-05-16	Moyens pour stimuler le systeme immunitaire
NO964894L (no)	1996-11-18	Rekombinante viruser, deres fremstilling samt anvendelse av genterapi
ATE315082T1 (de)	2006-02-15	Myeloider koloniestimulierungsfaktor und verwendungen davon
WO2000024876A3 (fr)	2000-11-02	Nouveau retrovirus isole chez l'homme

Legal Events

Date	Code	Title	Description
2010-01-29	REFS	Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)